| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Unrealized gain on investments | 0 | 0 | - | 15 |
| Foreign currency translation adjustment | -176 | 979 | 805 | 407 |
| Other comprehensive income (loss) | -176 | 979 | 805 | 422 |
| Cost of revenue | 32,937 | 34,657 | 30,992 | 29,117 |
| Revenue | 134,269 | 136,139 | 123,620 | 115,910 |
| Gross profit | 101,332 | 101,482 | 92,628 | 86,793 |
| Research and development expenses | 22,892 | 29,284 | 22,528 | 20,960 |
| Selling, general and administrative expenses | 78,232 | 78,390 | 76,054 | 73,238 |
| Total operating expenses | 101,124 | 107,674 | 98,582 | 94,198 |
| Income (loss) from operations | 208 | -6,192 | -5,954 | -7,405 |
| Interest expense | 1,468 | 1,490 | 1,416 | 1,667 |
| Interest income | 1,165 | 941 | 1,042 | 1,281 |
| Loss on debt extinguishment | 0 | 0 | - | - |
| Other income | 9 | 812 | -180 | 260 |
| Loss before income tax expense | -86 | -5,929 | -6,508 | -7,531 |
| Income tax expense | 181 | 261 | 239 | 322 |
| Net loss | -267 | -6,190 | -6,747 | -7,853 |
| Comprehensive loss, net of tax | -443 | -5,211 | -5,942 | -7,431 |
| Basic net loss per share (in usd per share) | -0.01 | -0.13 | -0.14 | -0.17 |
| Diluted net loss per share (in usd per share) | -0.01 | -0.13 | -0.14 | -0.17 |
| Weighted average shares outstandingbasic (in shares) | 47,920,000 | 47,721,000 | 47,393,000 | 47,105,000 |
| Weighted average shares outstandingdiluted (in shares) | 47,920,000 | 47,721,000 | 47,393,000 | 47,105,000 |
AtriCure, Inc. (ATRC)
AtriCure, Inc. (ATRC)